Euro area vs Malta: Cause of death, by non-communicable diseases, ages 15-59, female
Euro area
81.6%
in 2021
Malta
85.6%
in 2021
Euro area rank
1st
Malta rank
3rd
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Euro area
- Malta
How they compare
Malta currently reports 85.6% against 81.6% in Euro area, a difference of 4.0%.
Across all 6 years both countries report, Malta has been ahead every year.
Euro area ranks 1st and Malta ranks 3rd of 47 groups.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Euro area | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 83.1% | 86.5% | 3.4% | Malta |
| 2010s | 86.9% | 90.6% | 3.7% | Malta |
| 2020s | 82.8% | 87.3% | 4.5% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Euro area or Malta?
- Malta, at 85.6% against 81.6% in Euro area as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Euro area and Malta?
- 4.0%, with Malta ahead.
- How many years of comparable data are there for Euro area and Malta?
- 6 years are reported by both, from 2000 to 2021.
- How do Euro area and Malta rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Euro area ranks 1st and Malta ranks 3rd of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.